BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37027330)

  • 61. End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.
    Parekh C; Gaynon PS; Abdel-Azim H
    Pediatr Blood Cancer; 2015 Nov; 62(11):2040-3. PubMed ID: 25976383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early T-cell precursor acute lymphoblastic leukemia with
    Tran T; Krause J
    Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):511-513. PubMed ID: 30948995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia.
    Ashry MSE; Radwan E; Abdellateif MS; Arafah O; Hassan NM
    J Egypt Natl Canc Inst; 2023 Jun; 35(1):17. PubMed ID: 37303010
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report.
    Imataki O; Fujita H; Uemura M
    Case Rep Oncol; 2024; 17(1):256-261. PubMed ID: 38362442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical Features and Prognosis of Acute T-cell Lymphoblastic Leukemia in Children--Multi-Center Data Analysis in Fujian].
    Wu CP; Zheng YZ; Li J; Wen H; Weng KZ; Zhuang SQ; Wu XG; Hua XL; Zheng H; Chen ZS; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):6-13. PubMed ID: 38387892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The treatment development for T cell acute lymphoblastic leukemia in children, adolescents, and young adults].
    Sato A
    Rinsho Ketsueki; 2022; 63(9):1325-1334. PubMed ID: 36198559
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment and Prognosis of Adult T Cell Acute Lymphoblastic Leukemia].
    Huang ZF; Wang TY; Fu MW; Liu W; Hao M; Qiu LG; Zou H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):485-491. PubMed ID: 31484610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early T-cell precursor acute lymphoblastic leukemia with Auer rods in mature granulocytes.
    Wang Y; Zhang Z; Xi L; Wang H; Dong F
    Int J Lab Hematol; 2022 Apr; 44(2):e52-e54. PubMed ID: 34559445
    [No Abstract]   [Full Text] [Related]  

  • 70. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
    Gibson A; Trabal A; McCall D; Khazal S; Toepfer L; Bell DH; Roth M; Mahadeo KM; Nunez C; Short NJ; DiNardo C; Konopleva M; Issa GC; Ravandi F; Jain N; Borthakur G; Kantarjian HM; Jabbour E; Cuglievan B
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
    Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
    PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Identification of Differentially Expressed Gene Core Genes in Early T-Cell Precursor Acute Lymphoblastic Leukemia and Its Regulatory Network Analysis].
    Lun YZ; Sun J; Yu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):673-684. PubMed ID: 31204916
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
    Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
    Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
    Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
    J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 76. [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation].
    Chen X; Liu ZY; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; He Y; Wei JL; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):542-549. PubMed ID: 36709130
    [No Abstract]   [Full Text] [Related]  

  • 77. Comparison of flowcytometry-based scoring system for the diagnosis of early T precursor-acute lymphoblastic leukemia.
    Marballi Basavaraju D; Mishra S; Chhabra G; Chougule S
    Cytometry B Clin Cytom; 2023 Nov; 104(6):453-459. PubMed ID: 36892134
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15.
    Inukai T; Kiyokawa N; Campana D; Coustan-Smith E; Kikuchi A; Kobayashi M; Takahashi H; Koh K; Manabe A; Kumagai M; Ikuta K; Hayashi Y; Tsuchida M; Sugita K; Ohara A
    Br J Haematol; 2012 Feb; 156(3):358-65. PubMed ID: 22128890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
    Kumar A; Drusbosky LM; Meacham A; Turcotte M; Bhargav P; Vasista S; Usmani S; Pampana A; Basu K; Tyagi A; Lala D; Rajagopalan S; Birajdar SC; Alam A; Ghosh Roy K; Abbasi T; Vali S; Sengar M; Chinnaswamy G; Shah BD; Cogle CR
    Leuk Res; 2019 Mar; 78():3-11. PubMed ID: 30641417
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Outcome of childhood T-cell acute lymphoblastic leukemia: a report of 99 cases].
    Cai JY; Xue HL; Chen J; Shen SH; Pan C; Wang X; Zhou M; Tang YJ; Gao YJ; Wang JM; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):456-60. PubMed ID: 27256235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.